Cells from placentas safe for patients with multiple sclerosis

Early evidence suggests value treatment effectiveness

2014-09-29

(Press-News.org) Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions.

While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble "mesenchymal," stromal stem cells found in connective tissue in bone marrow, but unlike their bone-marrow derived counterparts, stromal cells from the placenta are more numerous, with one donor able to supply enough cells for many patients.

"This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis," said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. "The next step will be to study larger numbers of MS patients to assess efficacy of the cells, but we could be looking at a new frontier in treatment for the disease."

MS is a chronic autoimmune disease in which the body's immune system mounts recurring assaults on the myelin--the fatty, protective coating around nerve fibers in the central nervous system. This causes nerves to malfunction and can lead to paralysis and blindness. The disease usually begins as an episodic disorder called relapsing-remitting MS (RRMS), and for many sufferers, evolves into a chronic condition with worsening disability called secondary progressive MS (SPMS).

The new safety study was conducted on 16 MS patients (10 with RRMS and six with SPMS) between the ages of 18 and 65. Six patients were given a high dose of PDA-001, another six were given a lower dose, and four patients were given placebo. Any time the immune system is altered, say by an experimental treatment, there is always a risk for MS to worsen, noted Dr. Lublin. All subjects were given monthly brain scans over a six-month period to ensure they did not acquire any new or enlarging brain lesions, which would indicate a worsening of MS activity. No subjects showed any paradoxical worsening on MRI and after one year, the majority had stable or improved levels of disability.

"We're hoping to learn more about how placental stromal cells contribute to myelin repair," said Dr. Lublin. "We suspect they either convert to a myelin making cell, or they enhance the environment of the area where the damage is to allow for natural repair. Our long-term goal is to develop strategies to facilitate repair of the damaged nervous system."

INFORMATION:

Collaborators in the study included the Swedish Neuroscience Institute in Seattle, WA, MultiCare Health System-Neuroscience Center of Washington, London Health Sciences Centre at University Hospital in London, the Clinical Neuroscience Research Unit at the University of Minnesota, the University of Colorado Denver, The Ottawa Hospital Multiple Sclerosis Clinic, and the MS Comprehensive Care Center at SUNY.

Dr. Fred Lublin has received research support and financial compensation as an advisory board member from Celgene, the study's sponsor.

About the Mount Sinai Health System:

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report. For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.

ELSE PRESS RELEASES FROM THIS DATE:

Greenland Ice Sheet more vulnerable to climate change than previously thought

2014-09-29

A new model developed by researchers at the University of Cambridge has shown that despite its apparent stability, the massive ice sheet covering most of Greenland is more sensitive to climate change than earlier estimates have suggested, which would accelerate the rising sea levels that threaten coastal communities worldwide. In addition to assessing the impact of the increasing levels of meltwater created and spilled into the ocean each year as the climate continues to warm, the new model also takes into account the role that the soft, spongy ground beneath the ice ...

Scientists discover a new role for estrogen in the pathology of breast cancer

2014-09-29

CHAMPAIGN, Ill. — Scientists have discovered a previously unknown mechanism by which estrogen prepares cells to divide, grow and, in the case of estrogen-positive breast cancers, resist cancer drugs. The researchers say the work reveals new targets for breast cancer therapy and will help doctors predict which patients need the most aggressive treatment. The University of Illinois team reports its findings in the journal Oncogene. Estrogen pre-activates the unfolded-protein response (UPR), a pathway that normally protects cells from stress, the researchers report. The ...

Climate change appears a mixed bag for a common frog

2014-09-29

Scientists have found amphibians worldwide are breeding earlier due to climate change, but how that affects species is just now being answered. After warmer winters, wood frogs breed earlier and produce fewer eggs, a Case Western Reserve University researcher has found. Michael F. Benard, the George B. Mayer Chair in Urban and Environmental Studies and assistant professor of biology, also found that frogs produce more eggs during winters with more rain and snow. Benard's study, published today in the journal Global Change Biology, is among the first in a natural habitat ...

After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

2014-09-29

CHAMPAIGN, Ill. — A nine-month-long, randomized controlled trial involving 221 prepubescent children found that those who engaged in moderate-to-vigorous physical activity for at least 60 minutes a day after school saw substantial improvements in their ability to pay attention, avoid distraction and switch between cognitive tasks, researchers report in the journal Pediatrics. Half of the study subjects were randomly assigned to the after-school program and the rest were placed on a wait list. All participants underwent cognitive testing and brain imaging before and after ...

Hand size appears to stay constant, providing natural 'ruler'

2014-09-29

People tend to perceive their dominant hand as staying relatively the same size even when it's magnified, lending support to the idea that we use our hand as a constant perceptual "ruler" to measure the world around us. The findings are published in Psychological Science, a journal of the Association for Psychological Science. "These findings suggest that our bodies are used as perceptual metrics, meaning that we are more likely to attribute changes in the perceived size of the hand to changes in the world — instead of thinking that our hand has become bigger, we're more ...

More children admitted to intensive care but with lower staffing ratios

2014-09-29

More children than ever are being admitted to intensive care units in England and Wales but there are fewer staff per bed available to cope with the increase, according to a new report published jointly by the University of Leeds and University of Leicester. The Paediatric Intensive Care Audit Network (PICANet) report showed that there was a 15% increase in admissions over a 10-year period between 2004 and 2013, but this included an increase of 4% that was not due to changes in the childhood population. At the same time, staffing levels have increased by 36% but this ...

Researchers identify early sign of pancreatic cancer

2014-09-28

BOSTON –– Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear. The research is being published online today by the journal Nature Medicine. Although the increase isn't large enough to be the basis of a new test for early detection of the disease, the findings will help researchers better understand how pancreatic cancer affects the rest of the body, ...

Human genome was shaped by an evolutionary arms race with itself

2014-09-28

New findings by scientists at the University of California, Santa Cruz, suggest that an evolutionary arms race between rival elements within the genomes of primates drove the evolution of complex regulatory networks that orchestrate the activity of genes in every cell of our bodies. The arms race is between mobile DNA sequences known as "retrotransposons" (a.k.a. "jumping genes") and the genes that have evolved to control them. The UC Santa Cruz researchers have, for the first time, identified genes in humans that make repressor proteins to shut down specific jumping ...

Docetaxel or pemetrexed with cisplatin achieve comparable outcomes in non-squamous Lu Ca

2014-09-27

The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events. At the ESMO 2014 Congress in Madrid, Dr Young-Chul Kim from Chonnam National University Medical School, South Korea, reported the results of an open-label phase III trial that included 149 patients with non-squamous non-small cell lung cancer (NSCLC) conducted at 14 centres in South Korea. "We wanted ...

Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies

2014-09-27

Measuring the expression levels of an enzyme involved in DNA synthesis can help predict the response of lung cancers to certain treatments, a Korean study has shown at the ESMO 2014 Congress in Madrid. In a randomized phase II study, researchers showed that patients whose lung cancers expressed low levels of an enzyme called thymidylate synthase experienced a greater benefit from treatment with the combination of pemetrexed and cisplatin than those whose tumours expressed high levels. "Thymidylate synthase is one of the proteins that is targeted by pemetrexed which ...

DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring

Davos Alzheimer's Collaborative launches innovative brain health navigator program for intuitive coordination between patients and providers

Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screeninge

Study published in NEJM Catalyst finds patients cared for by MedStar Health’s Safe Babies Safe Moms program have better outcomes in pregnancy, delivery, and postpartum

Cells from placentas safe for patients with multiple sclerosis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: